ATE417060T1 - Proteinallergenderivate - Google Patents

Proteinallergenderivate

Info

Publication number
ATE417060T1
ATE417060T1 AT05812763T AT05812763T ATE417060T1 AT E417060 T1 ATE417060 T1 AT E417060T1 AT 05812763 T AT05812763 T AT 05812763T AT 05812763 T AT05812763 T AT 05812763T AT E417060 T1 ATE417060 T1 AT E417060T1
Authority
AT
Austria
Prior art keywords
protein allergen
allergenic activity
wild
derivatives
type protein
Prior art date
Application number
AT05812763T
Other languages
English (en)
Inventor
Kerstin Westritschnig
Margarete Focke
Peter Valent
Walter Keller
Rudolf Valenta
Original Assignee
Biomay Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36202602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE417060(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomay Ag filed Critical Biomay Ag
Application granted granted Critical
Publication of ATE417060T1 publication Critical patent/ATE417060T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05812763T 2004-12-02 2005-12-02 Proteinallergenderivate ATE417060T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0202804A AT501101B1 (de) 2004-12-02 2004-12-02 Protein-allergen-derivat
EP05812763A EP1817330B1 (de) 2004-12-02 2005-12-02 Proteinallergenderivate

Publications (1)

Publication Number Publication Date
ATE417060T1 true ATE417060T1 (de) 2008-12-15

Family

ID=36202602

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0202804A AT501101B1 (de) 2004-12-02 2004-12-02 Protein-allergen-derivat
AT05812763T ATE417060T1 (de) 2004-12-02 2005-12-02 Proteinallergenderivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0202804A AT501101B1 (de) 2004-12-02 2004-12-02 Protein-allergen-derivat

Country Status (11)

Country Link
US (1) US20080286311A1 (de)
EP (1) EP1817330B1 (de)
JP (1) JP2008521837A (de)
CN (1) CN101068830B (de)
AT (2) AT501101B1 (de)
AU (1) AU2005312324B2 (de)
CA (1) CA2589187A1 (de)
DE (1) DE602005011667D1 (de)
ES (1) ES2319218T3 (de)
PL (1) PL1817330T3 (de)
WO (1) WO2006058359A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709435B2 (en) 2003-01-21 2014-04-29 Biomay Ag Hypallergenic mosaic antigens and methods of making same
ES2307381B1 (es) 2006-04-12 2009-10-23 Bial Industrial Farmaceutica S.A. Proteinas quimericas hipoalergenicas pertenecientes a la familia de transportadoras de lipidos de parietaria judaica utiles para el tratami ento de alergias.
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
EP1872792A1 (de) * 2006-06-29 2008-01-02 Biotech Tools S.A. Methode zur Herstellung eines hydrolysierten Allergens
EP2436691B1 (de) * 2008-03-25 2017-08-02 Bial Industrial Farmaceutica, S.A. Hypoallergene hybridproteine der grösseren gruppe 1- und 2-mit-allergene zur verwendung bei der behandlung von allergien
EP2110383A1 (de) 2008-04-14 2009-10-21 Biomay AG Hypoallergene Varianten
EP2295076A1 (de) 2009-09-10 2011-03-16 Biomay Ag Hypoallergene Hybridpolypeptide zur Allergiebehandlung
CA2870399A1 (en) * 2012-04-16 2013-10-24 Alk-Abello A/S Plant profilin polypeptides for use in non-specific allergy immunotherapy
CN110055340B (zh) * 2019-04-11 2021-01-01 中国农业大学 一种食品中牛源成分快速检测方法及试剂盒
CN113173982B (zh) * 2021-04-14 2022-09-06 中国海洋大学 Rap v 2蛋白相关的抗原表位肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010297A1 (en) * 1987-06-17 1988-12-29 Princess Margaret Children's Medical Research Foun Cloning of mite allergens
US5433948A (en) * 1990-02-13 1995-07-18 Thomas; Wayne R. Cloning and sequencing of allergens of dermatophagoides (house dust mite)
CA2066801A1 (en) * 1991-04-26 1992-10-27 Shyam S Mohapatra Determination of dna sequences of a novel group of major grass pollen allergens and the synthesis of their correspsonding recombinant proteins
JPH1075783A (ja) * 1996-09-04 1998-03-24 Fumakilla Ltd 組換えダニアレルゲン
JP2001231563A (ja) * 2000-02-18 2001-08-28 Asahi Breweries Ltd 改変したダニアレルゲン（システイン変異体）及びその製造方法
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US7279295B2 (en) * 2002-03-27 2007-10-09 Phadia Ab Allergen
DE60205907T2 (de) * 2002-09-27 2006-02-16 Biomay Produktions- Und Handels-Aktiengesellschaft Hypoallergene Impfstoffe gegen Allergie basierend auf Lieschgraspollenallergen Phl p 7
US7384635B2 (en) * 2002-11-01 2008-06-10 Alk-Abello A/S Protein variants of naturally occurring allergens
ATE307141T1 (de) * 2003-01-21 2005-11-15 Biomay Prod & Handel Verfahren zur vorbereitung von hypoallergenen mosaikproteine

Also Published As

Publication number Publication date
WO2006058359A3 (en) 2006-07-27
PL1817330T3 (pl) 2009-06-30
EP1817330B1 (de) 2008-12-10
JP2008521837A (ja) 2008-06-26
AT501101A1 (de) 2006-06-15
CA2589187A1 (en) 2006-06-08
DE602005011667D1 (de) 2009-01-22
AT501101B1 (de) 2008-01-15
AU2005312324B2 (en) 2011-05-12
ES2319218T3 (es) 2009-05-05
CN101068830A (zh) 2007-11-07
EP1817330A2 (de) 2007-08-15
AU2005312324A1 (en) 2006-06-08
WO2006058359A2 (en) 2006-06-08
CN101068830B (zh) 2012-05-09
US20080286311A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
CY2018013I2 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
WO2005063820A3 (en) Il-7 fusion proteins
WO2012054929A3 (en) Use of human serum albumin to decrease antigenicity of therapeutic proteins
WO2009155324A3 (en) Pigf-1 assay and kits and components thereof
MX358705B (es) Agentes de union de esclerostina.
MX348432B (es) Epitopes.
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
AU2010273974A8 (en) Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts
WO2007095506A8 (en) Oligosaccharide modification and labeling of proteins
ATE489465T1 (de) Gezielte integration in die ppp1r12c-position
NO20070699L (no) Spesielle aminoalkylglukosaminidfosfatforbindelser og deres anvendelse
NO20091181L (no) Anti-C5AR-antistoffer med forbedrede egenskaper
DE602005011667D1 (de) Proteinallergenderivate
EP1930428A4 (de) Hefewirt, transformante und verfahren zur herstellung von fremdprotein
EP1969127B8 (de) Verfahren zur herstellung biologisch wirksamer vitamin-k-abhängiger proteine mit rekombinanten verfahren
EA200702193A1 (ru) Гликозилирование белков
WO2006125201A3 (en) Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
DE602006019849D1 (de) Proteinspaltungsverfahren und verwendung davon
WO2005086654A3 (en) Self-cleaving affinity tags and methods of use
TW200626073A (en) Activated globular protein and its use in edible compositions
WO2008015419A3 (en) Protein solubilisation
EP1759007A4 (de) Proteinkomplexierungsverfahren mittels dispersionssystem und proteine daraus
EP2389803A3 (de) Methoden unter Verwendung eines tierischen Osteopenie-Modells
WO2007002149A3 (en) Methods and compositions relating to a vaccine against prostate cancer
PL376122A1 (pl) Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties